HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of chemotherapy induced cardiomyopathy.

Abstract
Chemotherapy related cardiac dysfunction (CRCD) is a serious complication of anticancer therapy. CRCD can be classified into two types. Type I CRCD is exemplified by anthracyline- induced cardiac dysfunction and type II CRCD is exemplified by trastuzumab- induced cardiac dysfunction. The mechanism of cardiac toxicity in both types is not well defined. Certain risk factors may play a role in developing the cardiac injury, most importantly, the cumulative dose when dealing with anthracycline induced cardiotoxicity. Establishing an early diagnosis and initiating early treatment may be an important step in preventing irreversible cardiac injury especially in type I CRCD. Currently there are no guidelines developed specifically for the treatment of chemotherapy induced cardiomyopathy (CIC), however a few small studies support the use of neurohormonal antagonists in the treatment and prevention of CIC. Large multi- centers trials are needed to establish guidelines for CIC. Until then, we advocate following the American College of Cardiology/ American Heart Association (ACC/AHA) and Heart Failure Society of America (HFSA) guidelines. Additionally, a close collaboration between the patient's cardiologist and oncologist is strongly recommended in order to establish a long term plan for the patient.
AuthorsAbdulfattah Saidi, Rami Alharethi
JournalCurrent cardiology reviews (Curr Cardiol Rev) Vol. 7 Issue 4 Pg. 245-9 (Nov 2011) ISSN: 1875-6557 [Electronic] United Arab Emirates
PMID22758625 (Publication Type: Journal Article, Review)
Chemical References
  • Anthracyclines
  • Antineoplastic Agents
  • Cardiotoxins
Topics
  • Anthracyclines (adverse effects)
  • Antineoplastic Agents (adverse effects)
  • Cardiotoxins (adverse effects)
  • Early Diagnosis
  • Heart Failure (chemically induced, diagnosis, therapy)
  • Humans
  • Practice Guidelines as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: